Delivery Order SPE2DB22D3301-SPE2DB23FZ4WR

Award Date 9/12/23
Potential Completion Date 10/3/23
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,048 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from August 2nd to August 23rd, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military readiness by procuring and providing logistics support and supplies to the Department of Defense and partners worldwide. This small order...
The Defense Logistics Agency awarded a $3,931.80 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 100 vials of Xeomin, a botulinum toxin used for medical treatments. The prime contractor will deliver the products to a location in Conshohocken, Pennsylvania by September 13, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to support military...
The Defense Logistics Agency awarded a $18,872 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562150388 units of Xeomin 200 unit vials. The prime contractor will deliver the botulinum toxin type A injection to a facility located in Conshohocken, Pennsylvania by October 2, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to military treatment facilities worldwide. No...
The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 vials of Xeomin, a botulinum toxin type A. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by August 7, 2023 to support the agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for...
The Defense Logistics Agency awarded a $1,572 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin, a botulinum toxin used for medical treatments. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location through mid-August 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and distribution network, procuring a wide range...
The Defense Logistics Agency awarded a $4,718 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 vials of Xeomin, a botulinum toxin used for medical treatments. The contract has a period of performance from September 12, 2023 through October 3, 2023, with all items to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The order is to be performed in Conshohocken, Pennsylvania from August 18th through September 11th, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will supply the botulinum toxin type A injection to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, in support of its medical...
The Defense Logistics Agency awarded a $22,018 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from September 29th through October 23rd, 2023, this order is in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were specified. The award utilizes an existing DLA medical product contract vehicle to procure this botulinum toxin, supporting the...
The Defense Logistics Agency awarded a $1,572 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from August 8th to August 29th, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the botulinum toxin under this short-term requirement to support the Agency's medical readiness and logistics programs. No...
The Defense Logistics Agency awarded a $4,193.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 vials of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania under contract number 4562221776, the order runs from September 18, 2023 through October 10, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB23FZ4WR
    Delivery Order

The Defense Logistics Agency awarded a $1,425 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562168446 units of Xeomin 50 unit vials. The one month contract runs from September 12, 2023 to October 3, 2023 and will be performed in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to military personnel as needed. No subcontractors or set aside designations were identified for this short term order to procure the botulinum toxin drug from the pharmaceutical distributor.

Generated 12/19/23, 9:23 PM